Glycine supplementation has gained attention for potential benefits in supporting metabolic health during GLP-1 treatment
Generic and biosimilar semaglutide: what's actually in the pipeline As of April 2026, the FDA has received zero Abbreviated New Drug Applications (ANDAs) for generic semaglutide
Kyowa Hakko's research-backed branded ingredient, Cognizin, supports mental energy, focus, attention, and memory* all in a decadent dark chocolate-cherry square
Scientific interest in 5-Amino-1MQ often centers on its relationship to nicotinamide N-methyltransferase research and metabolic pathway investigation
People spoke about sudden unintended pregnancy, and Ozempic babies entered the lexicon
Everything felt maybe 5% easier at most, which for $45+ per month feels like I'm paying for placebo effect and nice packaging